Literature DB >> 33382690

Diagnostic accuracy of direct agglutination test, rK39 ELISA and six rapid diagnostic tests among visceral leishmaniasis patients with and without HIV coinfection in Ethiopia.

Mekibib Kassa1, Saïd Abdellati2, Lieselotte Cnops2, Bruno C Bremer Hinckel3, Arega Yeshanew1, Wasihun Hailemichael4, Florian Vogt2, Wim Adriaensen2, Pascal Mertens3, Ermias Diro1, Johan van Griensven2, Dorien Van den Bossche2.   

Abstract

Diagnosis of a first-time visceral leishmaniasis (VL) infection in Ethiopia is established by use of a rapid diagnostic test (RDT) detecting antibodies against rK39, direct agglutination test (DAT) and microscopy according to the national algorithm. The performance of individual tests and algorithm is variable and depends on several factors, one being HIV status. Limited data are available on the performance of tests in VL-HIV coinfected patients. Assessment of the performance of DAT (ITM-A), rK39 ELISA (Serion) and six RDT (Onsite Leishmania Ab CTK, Antigen ICT Xinjier, IT Leish Biorad, Kalazar Detect Inbios, rK39 IgG1 Coris, rk28 IgG1 Coris) for the diagnosis of VL was done on a panel of 91 stored serum and plasma samples of 'first-episode' suspected VL patients, with HIV coinfection (n = 51) and without (n = 40). A combined reference standard was used: either positive microscopy on tissue aspirates, or in case of negative microscopy, positive PCR results on the aspirate slide. Additionally, endemic healthy controls (n = 20), non-endemic controls (n = 10) and patients with confirmed malaria infection (n = 10) were tested for specificity evaluation. Sensitivities ranged from 69.2% for DAT (applied cut-off ≥ 1/3200) to 92.2% for the Onsite RDT, whereas specificities ranged from 20.0% for Kalazar Antigen ICT to 100% for IT Leish and rK39 IgG1. Sensitivities from all assays decreased upon stratification according to HIV status but was only significantly different for rK39 Serion ELISA (p-value 0.0084) and the Onsite RDT (p-value 0.0159). In conclusion, performance of commercially available assays for VL on samples from Northern-Ethiopian patients varied widely with a substantial decrease in sensitivity in the VL-HIV coinfected group. Clear guidelines on minimal performance criteria of individual tests and algorithms are needed, as well as which reference standard should be used to determine the performance.

Entities:  

Year:  2020        PMID: 33382690      PMCID: PMC7774845          DOI: 10.1371/journal.pntd.0008963

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  37 in total

1.  The STARD initiative.

Authors:  Patrick M Bossuyt; Johannes B Reitsma
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

Review 2.  Laboratory diagnosis of visceral leishmaniasis.

Authors:  Shyam Sundar; M Rai
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 3.  Rapid tests for sexually transmitted infections (STIs): the way forward.

Authors:  R W Peeling; K K Holmes; D Mabey; A Ronald
Journal:  Sex Transm Infect       Date:  2006-12-06       Impact factor: 3.519

4.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

5.  HIV-Leishmania co-infections in Italy: serological data as an indication of the sequence of acquisition of the two infections.

Authors:  L Gradoni; A Scalone; M Gramiccia
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 Jan-Feb       Impact factor: 2.184

Review 6.  Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease.

Authors:  Marleen Boelaert; Kristien Verdonck; Joris Menten; Temmy Sunyoto; Johan van Griensven; Francois Chappuis; Suman Rijal
Journal:  Cochrane Database Syst Rev       Date:  2014-06-20

Review 7.  Comparative study of rK39 Leishmania antigen for serodiagnosis of visceral leishmaniasis: systematic review with meta-analysis.

Authors:  Zuinara Maia; Monique Lírio; Sóstenes Mistro; Carlos Maurício Cardeal Mendes; Sanjay R Mehta; Roberto Badaro
Journal:  PLoS Negl Trop Dis       Date:  2012-01-31

8.  Heterogeneity of Leishmania donovani parasites complicates diagnosis of visceral leishmaniasis: comparison of different serological tests in three endemic regions.

Authors:  Elfadil Abass; Cholho Kang; Franjo Martinkovic; Saul J Semião-Santos; Shyam Sundar; Peter Walden; Renaud Piarroux; Abdallah El Harith; Michael Lohoff; Ulrich Steinhoff
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

9.  Visceral Leishmaniasis in a UK Toddler following a Short Trip to a Popular Holiday Destination in Spain.

Authors:  Neda Minakaran; Talha Soorma; Shamez N Ladhani
Journal:  Case Rep Infect Dis       Date:  2014-08-10

10.  Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.

Authors:  Tegwen Marlais; Tapan Bhattacharyya; Om Prakash Singh; Pascal Mertens; Quentin Gilleman; Caroline Thunissen; Bruno C Bremer Hinckel; Callum Pearson; Bathsheba L Gardner; Stephanie Airs; Marianne de la Roche; Kiera Hayes; Hannah Hafezi; Andrew K Falconar; Osama Eisa; Alfarazdeg Saad; Basudha Khanal; Narayan Raj Bhattarai; Suman Rijal; Marleen Boelaert; Sayda El-Safi; Shyam Sundar; Michael A Miles
Journal:  Front Cell Infect Microbiol       Date:  2018-12-13       Impact factor: 5.293

View more
  2 in total

1.  ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.

Authors:  Nathalia C Galvani; Amanda S Machado; Daniela P Lage; Camila S Freitas; Danniele L Vale; Daysiane de Oliveira; Fernanda Ludolf; Fernanda F Ramos; Bruna B Fernandes; Gabriel P Luiz; Débora V C Mendonça; João A Oliveira-da-Silva; Thiago A R Reis; Grasiele S V Tavares; Ana T Chaves; Nathalia S Guimarães; Unaí Tupinambás; Gláucia F Cota; Maria V Humbert; Vívian T Martins; Myron Christodoulides; Eduardo A F Coelho; Ricardo A Machado-de-Ávila
Journal:  Parasitol Res       Date:  2021-10-19       Impact factor: 2.289

2.  Diagnostic Performance of Three rK39 Rapid Diagnostic Tests and Two Direct Agglutination Tests for the Diagnosis of Visceral Leishmaniasis in Southern Iran.

Authors:  Zahra Rezaei; Bahman Pourabbas; Vera Kühne; Parham Pourabbas; Philippe Büscher
Journal:  J Trop Med       Date:  2022-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.